The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
So the SP got poked with the RNS stick and..... flatlined. I See no mention of loo roll change or coffee pot refill then, guess that will be the next RNS.
LOL.
Yes golf17 can’t agree more this stock is seriously undervalued as it could save lives and governments millions on healthcare
This shared has been manipulated since release, once a hefty RNS comes in, we will easily see a 60% rise, hopefully this is when the manipulators will get caught with there trouser down and we can shift up to 8p as per recommendations.
Market will catch up sooner or later! This share has legs . Don’t let go of your shares so cheaply GLA
those are some chunky sells but in spite of that and the RNS the price has stayed put at 2.65
I'm still down on my pi, yet was thinking to load up based on the RNS but even comments on their facebook page suggest lack of faith in the BoDs. And that the product hasn't been snapped up by government during Covid despite it's beneficial claims. Am not a deramper btw. Just bemused why the price has sat stagnant after a seemingly positive, if not regurgitated, RNS. I've only been doing shares for 3 weeks btw, and haemorrhaging on POLX & PFC so forgive my ignorance if I missed something.
They are using a tried and tested method of....
Sell on good news,
Buy on bad news.
It's worked for Warren Buffet for years!
All these numpties selling trying to manipulate the price down for more gains will get caught out by a RNS and will end up paying a higher price . Will be back around 9-10p in no time , just a bit of patience required
December looking good already with sales from Europe
Already bigger than last Quarter and India could be a new Deal on the cards if trial successfully completed.GLA
Lovely update looking forward to 2022 should be transformational GLA